Multiparameter single-cell profiling of human CD4+FOXP3+ regulatory T-cell populations in homeostatic conditions and during graft-versus-host disease

Blood

Volumn 122, Issue 10, 2013, Pages 1802-1812

  Dong, Shen ^a   Maiella, Sylvie ^a   Xhaard, Aliénor ^b   Pang, Yuanyu ^a   Wenandy, Lynn ^a   Larghero, Jérome ^b,c   Becavin, Christophe ^d   Benecke, Arndt ^d   Bianchi, Elisabetta ^a   Socié, Gérard ^b,c   Rogge, Lars ^a,c,e  

^a CNRS   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c INSERM   (France)

^d INSTITUT DES HAUTES ÉTUDES SCIENTIFIQUES   (France)

^e INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR6; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 22; INTERLEUKIN 26; INTERLEUKIN 4; INTERLEUKIN 7 RECEPTOR; MESSENGER RNA; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR T BET; CD4 ANTIGEN; CD45 ANTIGEN; CYTOKINE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; HLA DR ANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CD4+ FOXP3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL HETEROGENEITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EFFECTOR CELL; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; NUCLEAR REPROGRAMMING; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SINGLE CELL ANALYSIS; T LYMPHOCYTE; ACUTE DISEASE; ALLOTRANSPLANTATION; GENE EXPRESSION PROFILING; GENETICS; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; METABOLISM; METHODOLOGY; PATHOLOGY; SECRETION (PROCESS);

ACUTE DISEASE; ADULT; ANTIGENS, CD4; ANTIGENS, CD45; CYTOKINES; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION PROFILING; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA-DR ANTIGENS; HOMEOSTASIS; HUMANS; SINGLE-CELL ANALYSIS; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, HOMOLOGOUS;

EID: 84886573982     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-02-482539     Document Type: Article

References (50)

1. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155(3): 1151-1164.
2. Sakaguchi S. Naturally arising CD41 regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004;22:531-562.
3. Sakaguchi S, Powrie F, Ransohoff RM. Reestablishing immunological self-tolerance in autoimmune disease. Nat Med. 2012;18(1): 54-58.
4. Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. 2012;30:531-564.
5. Roncarolo MG, Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol. 2007; 7(8):585-598.
6. Shevach EM. From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity. 2006; 25(2):195-201.
7. Feuerer M, Hill JA, Mathis D, Benoist C. Foxp31 regulatory T cells: differentiation, specification, subphenotypes. Nat Immunol. 2009;10(7): 689-695.
8. Shevach EM. Mechanisms of foxp31 T regulatory cell-mediated suppression. Immunity. 2009;30(5): 636-645.
9. Campbell DJ, Koch MA. Phenotypical and functional specialization of FOXP31 regulatory T cells. Nat Rev Immunol. 2011;11(2):119-130.
10. Takahata Y, Nomura A, Takada H, et al. CD251CD41 T cells in human cord blood: an immunoregulatory subset with naive phenotype and specific expression of forkhead box p3 (Foxp3) gene. Exp Hematol. 2004;32(7):622-629.
11. Valmori D, Merlo A, Souleimanian NE, Hesdorffer CS, Ayyoub M. A peripheral circulating compartment of natural naive CD4 Tregs. J Clin Invest. 2005; 115(7):1953-1962.
12. Baecher-Allan C, Wolf E, Hafler DA. MHC class II expression identifies functionally distinct human regulatory T cells. J Immunol. 2006;176(8): 4622-4631.
13. Ito T, Hanabuchi S, Wang YH, et al. Two functional subsets of FOXP31 regulatory T cells in human thymus and periphery. Immunity. 2008; 28(6):870-880.
14. Miyara M, Yoshioka Y, Kitoh A, et al. Functional delineation and differentiation dynamics of human CD41 T cells expressing the FoxP3 transcription factor. Immunity. 2009;30(6):899-911.
15. Thornton AM, Korty PE, Tran DQ, et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymicderived from peripherally induced Foxp31 T regulatory cells. J Immunol. 2010;184(7): 3433-3441.
16. Duhen T, Duhen R, Lanzavecchia A, Sallusto F, Campbell DJ. Functionally distinct subsets of human FOXP31 Treg cells that phenotypically mirror effector Th cells. Blood. 2012;119(19): 4430-4440.
17. Xu L, Kitani A, Fuss I, Strober W. Cutting edge: regulatory T cells induce CD41CD25-Foxp3-T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol. 2007;178(11):6725-6729.
18. Yang XO, Nurieva R, Martinez GJ, et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity. 2008;29(1):44-56.
19. Oldenhove G, Bouladoux N, Wohlfert EA, et al. Decrease of Foxp31 Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity. 2009;31(5):772-786.
20. Zhou X, Bailey-Bucktrout SL, Jeker LT, et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol. 2009;10(9):1000-1007.
21. Koenen HJ, Smeets RL, Vink PM, van Rijssen E, Boots AM, Joosten I. Human CD25high Foxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood. 2008;112(6):2340-2352.
22. Valmori D, Raffin C, Raimbaud I, Ayyoub M. Human RORγt1 TH17 cells preferentially differentiate from naive FOXP31Treg in the presence of lineage-specific polarizing factors. Proc Natl Acad Sci U S A. 2010;107(45): 19402-19407.
23. McClymont SA, Putnam AL, Lee MR, et al. Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J Immunol. 2011;186(7):3918-3926.
24. Rubtsov YP, Niec RE, Josefowicz S, et al. Stability of the regulatory T cell lineage in vivo. Science. 2010;329(5999):1667-1671.
25. Miyao T, Floess S, Setoguchi R, et al. Plasticity of Foxp3(1) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity. 2012;36(2):262-275.
26. Cohen JL, Trenado A, Vasey D, Klatzmann D, Salomon BL. CD4(1)CD25(1) immunoregulatory T cells: new therapeutics for graft-versus-host disease. J Exp Med. 2002;196(3):401-406.
27. Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo activated and expanded CD4(1)CD25(1) immune regulatory cells inhibits graft-versus-host disease lethality. Blood. 2002;99(10):3493-3499.
28. Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S. Donor-type CD4(1)CD25(1) regulatory T cells suppress lethal acute graftversus-host disease after allogeneic bone marrow transplantation. J Exp Med. 2002;196(3):389-399.
29. Zorn E, Kim HT, Lee SJ, et al. Reduced frequency of FOXP31 CD41CD251 regulatory T cells in patients with chronic graft-versus-host disease. Blood. 2005;106(8):2903-2911.
30. Rieger K, Loddenkemper C, Maul J, et al. Mucosal FOXP31 regulatory T cells are numerically deficient in acute and chronic GvHD. Blood. 2006;107(4):1717-1723.
31. Riley JL, June CH, Blazar BR. Human T regulatory cell therapy: take a billion or so and call me in the morning. Immunity. 2009;30(5): 656-665.
32. Brunstein CG, Miller JS, Cao Q, et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood. 2011;117(3): 1061-1070.
33. Di Ianni M, Falzetti F, Carotti A, et al. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood. 2011;117(14):3921-3928.
34. Blazar BR, Murphy WJ, Abedi M. Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol. 2012;12(6):443-458.
35. Socié G, Blazar BR. Acute graft-versus-host disease: from the bench to the bedside. Blood. 2009;114(20):4327-4336.
36. Weiss L, Letimier FA, Carriere M, et al. In vivo expansion of naive and activated CD41CD251 FOXP31 regulatory T cell populations in interleukin-2-treated HIV patients. Proc Natl Acad Sci U S A. 2010;107(23):10632-10637.
37. Brysbaert G, Pellay FX, Noth S, Benecke A. Quality assessment of transcriptome data using intrinsic statistical properties. Genomics Proteomics Bioinformatics. 2010;8(1):57-71.
38. Tchitchek N, Dzib JF, Targat B, Noth S, Benecke A, Lesne A. CDS: a fold-change based statistical test for concomitant identification of distinctness and similarity in gene expression analysis. Genomics Proteomics Bioinformatics. 2012;10(3): 127-135.
39. Pesenacker AM, Bending D, Ursu S, Wu Q, Nistala K, Wedderburn LR. CD161 defines the subset of FoxP31 T cells capable of producing proinflammatory cytokines. Blood. 2013;121(14): 2647-2658.
40. Bailey-Bucktrout SL, Bluestone JA. Regulatory T cells: stability revisited. Trends Immunol. 2011; 32(7):301-306.
41. Getnet D, Grosso JF, Goldberg MV, et al. A role for the transcription factor Helios in human CD4(1)CD25(1) regulatory T cells. Mol Immunol. 2010;47(7-8):1595-1600.
42. Hill JA, Feuerer M, Tash K, et al. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity. 2007;27(5):786-800.
43. Beriou G, Costantino CM, Ashley CW, et al. IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood. 2009;113(18): 4240-4249.
44. Dominguez-Villar M, Baecher-Allan CM, Hafler DA. Identification of T helper type 1-like, Foxp31 regulatory T cells in human autoimmune disease. Nat Med. 2011;17(6):673-675.
45. Ermann J, Hoffmann P, Edinger M, et al. Only the CD62L1 subpopulation of CD41CD251 regulatory T cells protects from lethal acute GVHD. Blood. 2005;105(5):2220-2226.
46. Taylor PA, Panoskaltsis-Mortari A, Swedin JM, et al. L-Selectin(hi) but not the L-selectin(lo) CD41251 T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood. 2004; 104(12):3804-3812.
47. Ukena SN, Velaga S, Geffers R, et al. Human regulatory T cells in allogeneic stem cell transplantation. Blood. 2011;118(13):e82-e92.
48. Matsuoka K, Kim HT, McDonough S, et al. Altered regulatory T cell homeostasis in patients with CD41 lymphopenia following allogeneic hematopoietic stem cell transplantation. J Clin Invest. 2010;120(5):1479-1493.
49. Gottschalk RA, Corse E, Allison JP. Expression of Helios in peripherally induced Foxp31 regulatory T cells. J Immunol. 2012;188(3):976-980.
50. Akimova T, Beier UH, Wang L, Levine MH, Hancock WW. Helios expression is a marker of T cell activation and proliferation. PLoS ONE. 2011;6(8):e24226.